Century Therapeutics, Inc.
NASDAQ: IPSC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Brent Pfeiffenberger
- Employees
- 140
- Headquarters
- Philadelphia, United States
- IPO year
- 2021
- Market cap
- $198.2M
- Website
- https://www.centurytx.com
Loading IPSC…
Loading profile data…Frequently asked questions about IPSC
What does Century Therapeutics, Inc. (IPSC) do?
Century Therapeutics, Inc. is a biotechnology company dedicated to pioneering allogeneic cell therapies for a range of cancers, specifically solid tumors and hematological malignancies. The firm's foremost clinical program is CNTY-101, an allogeneic, induced pluripotent stem cell (iPSC)-derived CAR-iNK cell therapy. This therapy is specifically...
Where does IPSC trade?
Century Therapeutics, Inc. (IPSC) trades on the NASDAQ Global Select.
What sector is IPSC in?
Century Therapeutics, Inc. (IPSC) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Century Therapeutics, Inc.?
Brent Pfeiffenberger is the chief executive officer of Century Therapeutics, Inc. (IPSC).
Where is Century Therapeutics, Inc. headquartered?
Century Therapeutics, Inc. is headquartered in United States.
Does IPSC pay a dividend?
Century Therapeutics, Inc. (IPSC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IPSC go public?
Century Therapeutics, Inc. (IPSC) completed its initial public offering in 2021.